The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response
Kathleen M. Giacomini(University of California, San Francisco), Issam Zineh(United States Food and Drug Administration), Howard L. McLeod(Unknown), Todd C. Skaar(Indiana University School of Medicine), Anne Nguyen(Indiana University School of Medicine), Cathy Schaefer(Kaiser Permanente), Victor I. Reus(University of California, San Francisco), Deanna L. Kroetz(University of California, San Francisco), Richard M. Weinshilboum(Mayo Clinic), M. Eileen Dolan(National Institutes of Health), Christopher M. A. Brett(Center for Economic and Policy Research), Dan M. Roden(Garvan Institute of Medical Research), Rachel F. Tyndale(Centre for Addiction and Mental Health), Mark J. Ratain(University of Chicago), Daniel F. Hayes(University of Michigan–Ann Arbor), Scott T. Weiss(Outcomes Research Consortium), Ronald M. Krauss(University of California System), Kelan G. Tantisira(Brigham and Women's Hospital), Teri E. Klein(Palo Alto University), Russ B. Altman(Stanford University), David A. Flockhart(Indiana University – Purdue University Indianapolis), N L Benowitz(University of California, San Francisco), L Wang(Mayo Clinic), Alan R. Shuldiner(Regeneron (United States)), J. A. Johnson(University of Florida), Mary V. Relling(St. Jude Children's Research Hospital)
Cited by 243
Related Papers
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
|Nature Medicine|2013|4.4k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
On the Opportunities and Risks of Foundation Models
|arXiv (Cornell University)|2021|2.2k